Status:
COMPLETED
De-adoption of Oral Chlorhexidine Prophylaxis and Implementation of an Oral Care Bundle (CHORAL)
Lead Sponsor:
University of Toronto
Collaborating Sponsors:
Sunnybrook Health Sciences Centre
Toronto General Hospital
Conditions:
Mortality
Oral Health
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of the CHORAL study is to evaluate the de-adoption of oral chlorhexidine and the introduction of a bundle of oral care practices on selected outcomes in critically ill mechanically venti...
Detailed Description
Infrequent or ineffective oral care can lead to mouth discomfort and lung infection for patients treated with ventilators (breathing machines) in intensive care units (ICUs). A commonly used mouthwash...
Eligibility Criteria
Inclusion
- All patients who receive mechanical ventilation in the participating ICUs.
Exclusion
- Does not meet inclusion criteria.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
3260 Patients enrolled
Trial Details
Trial ID
NCT03382730
Start Date
December 1 2017
End Date
January 1 2020
Last Update
May 9 2022
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
Toronto, Ontario, Canada
2
St. Michael's Hospital
Toronto, Ontario, Canada
3
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
4
Toronto General Hospital
Toronto, Ontario, Canada